The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis
Primary Purpose
Osteoarthritis
Status
Completed
Phase
Phase 2
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
mesenchymal stem cell
Placebo
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring knee joint osteoarthritis mesenchymal stem cell
Eligibility Criteria
Inclusion Criteria:
- Osteoarthritis diagnosed by MRI
Exclusion Criteria:
- Pregnancy or lactating
- Positive tests for HIV, HCV, HBV
- Active neurologic disorder
- End organ damage
- Uncontrolled endocrine disorder
Sites / Locations
- Royan Institute
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
mesenchymal stem cell
placebo
Arm Description
Patients with knee joint osteoarthritis who underwent intra articular mesenchymal stem cell injection.
The patients who are in control group and underwent placebo injection.
Outcomes
Primary Outcome Measures
physical function improvement
Evaluation the physical function improvement Measured by WOMAC osteoarthritis index after cell injection.
change in pain density
Evaluation the changing of pain density measured by Visual Analogue Scale after cell injection.
Secondary Outcome Measures
joint swelling
Evaluation the joint swelling by physical examination after intra articular cell injection.
joint erythema
Evaluation the joint erythem by physical examination after cell injection
deterioration of joint function
Evaluation the deterioration of joint function by physical examination after intra articular cell injection.
Allergic reactions
Evaluation the allergic reactions like skin rash,skin erythema,dyspenea by physical examination after cell injection
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01504464
Brief Title
The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis
Official Title
Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells in Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2015
Overall Recruitment Status
Completed
Study Start Date
October 2012 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
October 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Royan Institute
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Osteoarthritis of the knee is one of the most common causes of disability among elderly. As the disease progresses the cartilage become frustrated, surrounding bone react to become thicker and inflammation occurs in subchondral bone seen in T2-weighted MRI as increase in signal density. Patients are treated initially by pain management. In patients who don't response to first line treatment invasive treatment like total knee replacement is done. The investigators designed this clinical study with the aim of evaluating therapeutic effects of intra-articular injection of bone marrow mesenchymal stem cells (BM-MSCs) in patients with severe knee osteoarthritis.
Detailed Description
This is single center, randomized, triple blind phase II clinical study. Patients will be divided into two groups of case and control. All subjects will undergo bone marrow aspiration. Mesenchymal stem cells will be isolated from bone marrow, cultured and transplanted back to the knee joint. Patients of case group will receive cell injection 1 and 4 months after bone marrow aspiration. Placebo will be administered in this group 6 months after the first injection. Patients of control group will receive placebo 1 and 4 months after bone marrow aspiration. They all receive cell injection 6 months after first placebo injection. Follow up visit will occur at 2 and 6 weeks, and 3 and 6 months after the first injection. Radiological exams will be performed before and 6 months after the first injection by MRI. Clinical quantitative assessment will measure joint function by the WOMAC index and pain by the visual analogue scale.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
knee joint osteoarthritis mesenchymal stem cell
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
mesenchymal stem cell
Arm Type
Experimental
Arm Description
Patients with knee joint osteoarthritis who underwent intra articular mesenchymal stem cell injection.
Arm Title
placebo
Arm Type
Experimental
Arm Description
The patients who are in control group and underwent placebo injection.
Intervention Type
Biological
Intervention Name(s)
mesenchymal stem cell
Other Intervention Name(s)
stem cell transplantation
Intervention Description
intra articular injection of mesenchymal stem cell
Intervention Type
Biological
Intervention Name(s)
Placebo
Intervention Description
Patients with knee joint osteoarthritis who underwent intra articular placebo injection
Primary Outcome Measure Information:
Title
physical function improvement
Description
Evaluation the physical function improvement Measured by WOMAC osteoarthritis index after cell injection.
Time Frame
2weeks
Title
change in pain density
Description
Evaluation the changing of pain density measured by Visual Analogue Scale after cell injection.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
joint swelling
Description
Evaluation the joint swelling by physical examination after intra articular cell injection.
Time Frame
3months
Title
joint erythema
Description
Evaluation the joint erythem by physical examination after cell injection
Time Frame
3months
Title
deterioration of joint function
Description
Evaluation the deterioration of joint function by physical examination after intra articular cell injection.
Time Frame
3months
Title
Allergic reactions
Description
Evaluation the allergic reactions like skin rash,skin erythema,dyspenea by physical examination after cell injection
Time Frame
3months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Osteoarthritis diagnosed by MRI
Exclusion Criteria:
Pregnancy or lactating
Positive tests for HIV, HCV, HBV
Active neurologic disorder
End organ damage
Uncontrolled endocrine disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hamid Gourabi, PhD
Organizational Affiliation
Head of Royan Institute
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Nasser Aghdami, MD,PhD
Organizational Affiliation
Head of Royan Cell therapy Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Mohsen Emadeddin, MD
Organizational Affiliation
scientist
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royan Institute
City
Tehran
Country
Iran, Islamic Republic of
12. IPD Sharing Statement
Learn more about this trial
The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis
We'll reach out to this number within 24 hrs